ADMP inhibitors represent a specialized class of chemical compounds that target and modulate the activity of the protein ADMP (Anti-Dorsalizing Morphogenetic Protein), a member of the TGF-beta superfamily. This protein is involved in complex biochemical pathways, particularly in the regulation of developmental processes. By interacting with ADMP, these inhibitors are able to impact specific cellular signaling mechanisms, particularly those associated with morphogenetic gradients and developmental patterning. The intricate role of ADMP in modulating the balance between various growth factors like BMP (Bone Morphogenetic Protein) and other signaling molecules makes ADMP inhibitors valuable tools for investigating developmental biology and embryogenesis. They serve as molecular probes to delineate how ADMP exerts its effects on different developmental axes, such as the dorsal-ventral axis in vertebrates.
Chemically, ADMP inhibitors are diverse, often characterized by their ability to bind specific active sites or regulatory domains on the ADMP molecule. This binding disrupts the protein's interactions with other components of morphogenetic signaling pathways, thereby influencing cellular differentiation, proliferation, and apoptosis during critical stages of development. The structural diversity of ADMP inhibitors often includes small molecules or peptidomimetics that are engineered for high affinity and specificity to ADMP's active regions. Detailed biochemical studies of these inhibitors have provided insights into the conformational changes and molecular interactions necessary for ADMP's regulatory function. By inhibiting ADMP activity, these compounds offer a method to control or observe changes in the signaling dynamics that underlie the formation of complex tissue structures and patterning during development.
関連項目
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
BMPタイプI受容体の低分子阻害剤で、ADMP関連のシグナル伝達に影響を及ぼす可能性がある。 | ||||||
DMH-1 | 1206711-16-1 | sc-361171 sc-361171B sc-361171A sc-361171C | 10 mg 25 mg 50 mg 100 mg | $209.00 $312.00 $620.00 $1026.00 | 2 | |
選択的BMP受容体阻害剤で、ADMPが関与するシグナル伝達経路に影響を与える可能性がある。 | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $182.00 $736.00 | 28 | |
BMPタイプI受容体を標的としてBMPシグナル伝達を阻害し、ADMP活性に影響を及ぼす可能性がある。 | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
TGF-βスーパーファミリーのI型アクチビン受容体様キナーゼを阻害し、ADMP関連プロセスに影響を及ぼす可能性がある。 | ||||||
SB-505124 | 694433-59-5 | sc-362794 sc-362794A | 10 mg 50 mg | $321.00 $1350.00 | 2 | |
TGF-βシグナルの一部であるALK4、ALK5、ALK7を阻害し、ADMPの機能に影響を与える可能性がある。 | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $650.00 | 16 | |
ALK5、ALK4、ALK7を阻害し、ADMPが関与する経路に間接的に影響を及ぼす可能性がある。 | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $75.00 $150.00 $215.00 $650.00 $1224.00 $4296.00 $7818.00 | 8 | |
TGF-β受容体ALK5を阻害し、ADMP関連シグナル伝達に影響を及ぼす可能性がある。 | ||||||